
Tinkeso Therapeutics
Is to address the patient unmet needs with our novel off-the-shelf, allogeneic Natural Killer T (NKT) cell therapies for the treatment of cancers and other immune-mediated disorders.
About Tinkeso Therapeutics
Recent Funding lists Tinkeso Therapeutics under Health and bio. It went through IndieBio (IndieBio NY 09). It was founded by Emmie Fan and Xianzheng (Jerry) Zhou.
Funding rounds
- Website created
- IndieBio NY 09
IIndieBio · batchSource: indiebio.co
Founders and team
EF
Emmie Fan Co-Founder/CEOsource: tinkeso.comX(
Xianzheng (Jerry) Zhou Founder/CSO, Chairman of the Boardsource: tinkeso.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Tinkeso Therapeutics: questions and answers
- Who invested in Tinkeso Therapeutics?
- Investors on record for Tinkeso Therapeutics: IndieBio.
- Who founded Tinkeso Therapeutics?
- Tinkeso Therapeutics was founded by Emmie Fan (Co-Founder/CEO) and Xianzheng (Jerry) Zhou (Founder/CSO, Chairman of the Board).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tinkeso-therapeutics (get a free API key).